Gyre Therapeutics, Inc. (GYRE)
7.865
-0.60
(-7.03%)
USD |
NASDAQ |
Dec 11, 16:00
7.865
0.00 (0.00%)
After-Hours: 18:12
Gyre Therapeutics Market Cap: 757.66M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 4.853B |
| Savara, Inc. | 1.411B |
| Exelixis, Inc. | 11.09B |
| Vanda Pharmaceuticals, Inc. | 390.04M |
| Aldeyra Therapeutics, Inc. | 276.15M |
Market Cap Related Metrics
| PE Ratio | 206.97 |
| PS Ratio | 7.233 |
| Price to Book Value | 7.434 |
| Price | 7.865 |
| Earnings Yield | 0.48% |
| Operating PE Ratio | 64.47 |
| Normalized PE Ratio | 397.22 |